Delivery Order SPE2DP18D0010-SPE2DP18F5904
Award Date
9/21/18
Potential Completion Date
2/19/19
Potential Value
$93K
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $118,463.40. It is a firm fixed price delivery order contract, with no set-aside designation. Glaxosmithkline has received multiple federal contracts and...
This firm fixed-price delivery order contract was awarded by the Defense agency Medical Supply Chain to Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The $1,532,034 contract has a completion date of December 15, 2016 and was not set aside for any special designation. Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other products to government agencies, has received multiple federal contracts and grants to support...
This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the antiviral medication zanamivir, with a potential value of $938,448.00. It is a firm fixed price contract with no set-aside designation. Glaxosmithkline has provided a range of...
This federal contract award, SPE2DP16D0009/0020, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC. The $312,660.00 firm fixed price delivery order is for the antiviral medication zanamivir. The contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in North Carolina. Glaxosmithkline is a pharmaceutical company that provides vaccines, antivirals, and other products to various U.S. government agencies...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $80,651.20 and a completion date of February 19, 2019. The contract is not set aside for any particular business type. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies, including the Departments...
This is a delivery order awarded to Glaxosmithkline, LLC (doing business as Glaxosmithkline) by the Defense Medical Logistics Command, a subcomponent of the Defense Logistics Agency, for the purchase of the antiviral medication zanamivir. The $112,140.72 firm fixed price contract has an ultimate completion date of December 14, 2016 and was awarded on September 15, 2016. The contract is not designated as a set-aside. Glaxosmithkline is a pharmaceutical company that provides a range of products...
This contract award to Glaxosmithkline, LLC, a pharmaceutical company, was issued by the Defense Logistics Agency Troop Support Medical. The $414,326.61 firm fixed price purchase order is for the antiviral medication zanamivir. The contract has no set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts, including influenza vaccines,...
This $230,614.40 firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, to provide the antiviral medication zanamivir. The contract has a completion date of February 19, 2019 and was not set aside for any special business designation. Glaxosmithkline is a major pharmaceutical company that supplies vaccines, antivirals, and other medical countermeasures to federal agencies including the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $361,912.00. The contract is a firm fixed price Delivery Order, with no set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of products and services to U.S. government agencies, including vaccines, antiviral...